Medtronic Announces FDA Approval of Infuse Bone Graft in New Spine Surgery Indications Using PEEK Interbody Implants Medical Device Investing
Cytori Provides Update on US Manufacturing and EU Approval Plans for ATI-0918, Liposomal Doxorubicin Pharmaceutical Investing
Ultragenyx and Kyowa Kirin Announce Crysvita Now Launched in the U.S. for the Treatment of X–linked Hypophosphatemia Pharmaceutical Investing
Genocea Files Investigational New Drug Application for Neoantigen Cancer Vaccine Candidate GEN-009 Pharmaceutical Investing
Daré Bioscience announces funding award to further the development of Ovaprene Pharmaceutical Investing
Keryx Biopharmaceuticals Announces Changes to Management and Preliminary First Quarter 2018 Revenue Pharmaceutical Investing
Sanofi: FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma Pharmaceutical Investing
Eloxx Pharmaceuticals Announces FDA Grant of Orphan-Drug Designation for Investigational Drug ELX-02 for Treatment of Cystinosis Biotech Investing
Naturally Splendid Reports Year End Results for December 31, 2017 CEO Company Update Biotech Investing
